| Financial Year |
March 31 2023 |
| Monetary Funds |
219,186,426.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,952,501.27 |
| Accounts Receivable |
1,107,578,206.98 |
| Advances to Suppliers |
16,626,706.76 |
| Other Receivables |
55,458,170.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
297,748,690.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,437,676.37 |
| Total Current Assets |
2,503,047,895.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
783,062,652.73 |
| Long-term Equity Investment |
29,978,881.04 |
| Investment Properties |
-- |
| Fixed Assetes |
15,770,419.46 |
| Under-construction Projects |
500,267,202.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,999,285.08 |
| R&D expenses |
-- |
| Goodwill |
29,895,353.51 |
| Long-Term Deferred and Prepaid Expenses |
76,134,550.87 |
| Deferred Income Tax Assets |
359,442,904.68 |
| Other Non-Current Assets |
676,825,558.89 |
| Sub-Total of Non-Current Assets |
2,596,569,144.55 |
| Total Assets |
5,099,617,040.01 |
| Short-Term Loans |
686,022,240.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,826,774.05 |
| Accounts Payable |
1,822,153,995.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,167,958.91 |
| Taxes Payable |
4,100,879.77 |
| Interest Payable |
-- |
| Dividend Payable |
499,268.05 |
| Other payables |
371,874,876.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
88,407,957.61 |
| Other Current Liabilities |
98,817,024.21 |
| Sub-Total of Current Liabilities |
3,168,255,981.78 |
| Long-term Loans |
311,697,500.00 |
| Bonds Payable |
900,274,524.60 |
| Long-Term Accounts Payable |
101,213,333.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
36,066,513.60 |
| Deferred Income Tax Liabilities |
8,893.24 |
| Other Non-Current Liabilities |
56,202,304.25 |
| Sub-Total of Non-Current Liabilities |
1,410,852,322.89 |
| Total Liabilities |
4,579,108,304.67 |
| Paid-In Capital(Or Share Stock) |
612,767,053.00 |
| Capital Surplus |
1,279,510,236.44 |
| Surplus Reserve |
147,912,423.45 |
| LESS:Treasury Stock |
64,300,816.25 |
| Undistributed Profits |
-1,611,031,433.34 |
| Minority Stockholder's Interest |
55,506,836.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
465,001,898.68 |
| Owner's Equity（Stockholder's Equity） |
520,508,735.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,099,617,040.01 |
